Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02513043 · ClinicalTrials.gov registry record
Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine
A clinical trial of Pregnancy, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- 1,470
- Enrollment target
- 17
- Study locations
NCT02513043: Completed study of Pregnancy, sponsored by Gynuity Health Projects.
NCT02513043 is a study of Pregnancy that has completed, run by Gynuity Health Projects. The registered enrollment target is 1,470 participants, above the 865-participant average among 191 other Pregnancy trials with a reported enrollment target (70% higher). The trial reports 17 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02513043, a study of Pregnancy, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- 1,470 participants
- Enrollment target
- 17
- Study locations
Study Summary
This pilot study is designed to obtain preliminary data on the safety, acceptability, and feasibility of direct-to-consumer telemedicine abortion.
Primary Outcome
adverse events
Conditions Studied
Interventions
- DRUG medical abortion
Study Locations (17)
New York
- Choices Women's Medical Center - Jamaica
- Maine Family Planning - New York
Oregon
- Planned Parenthood Columbia Willamette - Portland
- Oregon Health and Sciences University Women's Health Research Unit - Portland
Washington
- Planned Parenthood Columbia Willamette - Washington
- Oregon Health and Sciences University Women's Health Research Unit - Washington
Colorado
- Planned Parenthood of the Rocky Mountains - Denver
District of Columbia
- Carafem - Washington D.C.
Georgia
- Carafem - Atlanta
Hawaii
- The University of Hawaii Women's Options Centers - Honolulu
Illinois
- Carafem - Skokie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,470 participants |
| Start Date | 2016-03-22 |
| Est. Completion | 2021-05-11 |
What the finished NCT02513043 record still lists
NCT02513043 is an observational study that tracks outcomes without assigning an intervention. Its 1,470 participants enrollment target places it among the larger protocols in the corpus, above the 865-participant average among 191 other Pregnancy trials with a reported enrollment target (70% higher).
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which medical abortion is the first listed.
NCT02513043 lists 17 locations in 14 states (New York, Oregon, Washington).
Frequently Asked Questions
What is clinical trial NCT02513043 about?
NCT02513043 is a clinical study titled "Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine". This pilot study is designed to obtain preliminary data on the safety, acceptability, and feasibility of direct-to-consumer telemedicine abortion.
What is the current status of trial NCT02513043?
This trial is currently completed. The enrollment target is 1,470 participants. The study started on 2016-03-22. Estimated completion is 2021-05-11.
What conditions does trial NCT02513043 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT02513043?
The interventions under investigation include: medical abortion (DRUG).
Who is sponsoring clinical trial NCT02513043?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02513043 being conducted?
This trial has 17 study locations across Colorado, District of Columbia, Georgia, Hawaii, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02513043's enrollment target sits among peer trials
1,470 20th of 191 higher than 172 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936361 · 1,456 participants · Phase 3
Statins In Intracerbral Hemorrhage
- NCT05869552 · 1,485 participants · NA
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI